Life Sciences Tools Stocks Scatter Chart

18 companies Industry in Healthcare P/E vs Revenue Growth (1y) (TTM)
Universe
Plot any two of 343 metrics The preset pairs are free. Subscribers can put any metric on either axis.
Highlight

P/E vs Revenue Growth (1y) (TTM)

Company Outlier, pinned to the edge Highlighted Trend

Each dot is one of the 18 Life Sciences Tools stocks, sized by market cap. The median Revenue Growth (1y) (TTM) is 5.7% and the median P/E 35.78. Pinned to the edge: 1 outliers on X and 1 on Y.

Rank correlation -0.03 Trend R² 0.02 X middle half 2.2% to 8.2% Y middle half 24.82 to 61.52
4High Revenue Growth (1y) (TTM), high P/E
5Low Revenue Growth (1y) (TTM), high P/E
4Low Revenue Growth (1y) (TTM), low P/E
5High Revenue Growth (1y) (TTM), low P/E

Quadrants split at the medians. Hover a dot for its true values; click to open the company. Outliers are more than 3× the interquartile range beyond the quartiles.

Companies

18 plotted
# Industry
1 TMOThermo Fisher Scientific 8.3% 36.63 $259.44B Life Sciences Tools
2 DHRDanaher 5.5% 37.87 $163.91B Life Sciences Tools
3 IDXXIdexx Laboratories 11.9% 46.96 $55.49B Animal Health
4 AAgilent Technologies 8.6% 34.06 $49.04B Life Sciences Tools
5 MTDMettler Toledo International 6.5% 37.17 $37.71B Industrial Machinery
6 IRIngersoll Rand 8.0% 23.71 $32.68B Pumps and Valves
7 ILMNIllumina 5.8% 34.93 $31.30B Life Sciences Tools
8 STESteris 8.1% 31.11 $25.67B Medical Devices
9 RVTYRevvity 4.6% 68.10 $17.25B Life Sciences Tools
10 CRLCharles River Laboratories International -1.2% 402.10OUT $16.18B Contract Research
11 TECHBio-Techne 0.9% 66.38 $11.43B Life Sciences Tools
12 QGENQiagen 2.2% 28.16 $10.82B Life Sciences Tools
13 DCIDonaldson 5.3% 22.12 $10.05B Industrial Machinery
14 BIOBio-Rad Laboratories 1.4% 9.59 $9.85B Life Sciences Tools
15 PGENPrecigen 2,388%OUT 66.64 $1.63B Gene and Cell Therapy
16 MLABMesa Laboratories 2.5% 117.72 $781.31M Life Sciences Tools
17 LABStandard Biotools -2.2% 2.10 $280.22M Life Sciences Tools
18 JANLJanel 16.0% 9.33 $51.01M Logistics

Frequently Asked Questions

Which Life Sciences Tools stocks look cheap relative to their growth?

Among Life Sciences Tools stocks, the largest companies growing revenue faster than the median (5.7%) while trading below the median P/E (35.78) are Agilent Technologies (A), Ingersoll Rand (IR), Illumina (ILMN), Steris (STE) and Janel (JANL). A low multiple next to fast growth can be an opportunity or a sign the market doubts the growth will last.

Which Life Sciences Tools stocks are expensive for their growth?

The largest companies with a P/E above the median and revenue growth below it are Danaher (DHR), Revvity (RVTY), Charles River Laboratories International (CRL), Bio-Techne (TECH) and Mesa Laboratories (MLAB).

What is the median P/E of Life Sciences Tools stocks?

The median P/E across the 18 Life Sciences Tools stocks plotted is 35.78, with the middle half between 24.82 and 61.52.

What is the median Revenue Growth (1y) (TTM) of Life Sciences Tools stocks?

The median is 5.7%, with the middle half between 2.2% and 8.2%.

Is there a relationship between Revenue Growth (1y) (TTM) and P/E for Life Sciences Tools stocks?

The rank correlation (Spearman) is -0.03, a no meaningful negative relationship: knowing one tells you little about the other.

How does this chart handle outliers?

A company whose value lies more than three interquartile ranges beyond the first or third quartile is treated as an outlier. By default it stays on the chart, pinned to the edge as an open marker, and its true value is shown in the tooltip and the table. In this view 1 companies are outliers on Revenue Growth (1y) (TTM) and 1 on P/E. You can switch to percentile clamping, exclude outliers, or plot raw values on a log scale.

Metrics from Business Quant's screener: trailing-twelve-month figures from SEC filings and multiples on the latest close. A company appears once even when it lists more than one share class. A company with a secondary business line in this industry is included unless you choose primary industry only. Nothing on this page is investment advice.